GNF351

CAS : 1227634-69-6

Ref. 3D-CZB63469

Informations sur le produit

• Nom: GNF351

Description

GNF351 is a growth factor that is structurally related to epidermal growth factor. It is a basic fibroblast growth factor (bFGF) with the amino acid sequence of Val-Ala-Gly-Arg-Leu-Lys. GNF351 binds to cellular receptors, which then initiate signal transduction pathways in response to extracellular stimuli. The binding of GNF351 to these receptors has been shown to induce cell proliferation and differentiation, as well as stimulation of angiogenesis and wound healing. This drug can be used for the treatment of autoimmune diseases, inflammatory skin diseases, and cancer. Treatment with GNF351 has been shown to inhibit the growth of liver cells in culture after chronic exposure, suggesting it may have a hepatoprotective effect. The detection time for this drug is very short; it can be detected in the blood after only 4 hours following administration.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 411.5 g/mol
• Formule: C₂₄H₂₅N₇
• Degré de pureté: Min. 95%